Company: CYTK
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001140361-25-013167
Chunk: 94

Company: CYTOKINETICS INC
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 94
---
 Stock and most recently in February 2023 by an additional 1,000,000 shares of Common Stock. The amounts in this line reflect the shares subject to these amendments to the 2004 EIP. The weighted-average exercise price reflects all of the awards outstanding pursuant to this provision of the 2004 EIP collectively. Outstanding RSUs have no exercise price. The weighted-average exercise price for the options granted pursuant to this provision, which are the only equity awards that have an exercise price, is $40.82. |

| 66 |     | Cytokinetics, Inc.|2025 Proxy Statement |

TABLE OF CONTENTS

Director Compensation Our non-employee director compensation program is designed to enhance our ability to attract and retain highly qualified directors and to align their interests with the long-term interests of our stockholders. The program consists of both a cash component, designed to compensate independent directors for their service on the Board of Directors and its committees, and an equity component, designed to align the interests of independent directors and stockholders in amounts that correlate to their responsibilities and levels of participation, including service on committees. Non-employee directors are also able to elect to receive their annual base retainers in equity, as further described below. We do not compensate members of the Board of Directors or committees on a per-meeting basis. Each year, Aon conducts a competitive review of our non-employee director compensation to ensure that our compensation practices and levels are appropriate and competitive. This analysis used the same group of Peer Companies that is used to evaluate executive compensation described above under “Compensation Discussion and Analysis.” Following this process and on the recommendation of Aon, the Compensation Committee revised the compensation mix and levels to reflect market median levels. Annual Retainers Our non-employee directors received annual base retainers in the amounts set forth below.

| Base Retainer             |     | Board of Directors Chair             |     | $85,000 |
|                           |     | Other directors                      |     | $50,000 |
| Committee Chair Retainer  |     | Audit Committee(1)                   |     | $25,000 |
|                           |     | Compliance Committee                 |     | $15,000 |
|                           |     | Compensation and Talent Committee(2) |     | $20,000 |
|                           |     | Nominating and Governance Committee  |     | $10,000 |
|                           |     | Science and Technology Committee     |     | $25,000 |
|                           |     | Transactions Committee